![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Ausun Pharmaceutical Co., Ltd. Taizhou Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Accelerating Development of APIs & Chemical Intermediates through innovation.
One of their significant offerings is Latanoprost, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-174 - Rev 00
This Chemical Type CEP, issued on October 23, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2230 associated with this CEP further emphasizes